Posts Tagged: R&D
Don’t Ignore the Flashing Caution Lights in the Drug Pricing Debate
Trying to rationally address hot button issues in an election year is always a dangerous proposition. That's particularly true as we approach what promises to be one …
The ‘Dragon’ Targets U.S. Biopharma Lead
Perhaps the report on China's strategy for eclipsing the U.S. lead in biopharma from the Information Technology & Innovation Foundation (ITIF) resonated so strongly with me because …
Bayh-Dole Rocks While the Critics Play the Same False Note
A just-released study co-sponsored by the Biotechnology Innovation Organization (BIO) and AUTM provides new evidence of the significant contribution academic patent licensing makes to the U.S. …
Restoring IP Rights After the Destructive, Unjust Antitrust Rendering in FTC v. Qualcomm
If a judge ever botched an antitrust case involving patents, the prize may go to federal district Judge Lucy Koh for her ruling in favor of the …
The Price of Price Controls: Innovation Likely to Suffer in Drug Pricing Debate
Is Congress really going to do anything useful with respect to lowering drug prices? When the question is presented that way the answer almost seems painfully obvious. …
Patent Trends Study Part Six: Medical Devices Industry
In the sixth installment of our 13-part patent-trends study (performed in collaboration with GreyB) providing high-level data across industries, we will examine trends in the medical-device industry. …
Apple is Afraid of Inventors, Not Patent Trolls
Apple made headlines with its recent decision to close its stores in Frisco and my home town of Plano, Texas. The rumor is that Apple was afraid …
Apple Pays for Its Patent Infringement, But Important Legal Cases Continue
n an age with instantaneous commentary on social media, the wheels of justice in courts seem to move at a glacial pace, especially in patent infringement lawsuits …
New Study Shows Bayh-Dole is Working as Intended—and the Critics Howl
Just as the drug pricing debate on Capitol Hill is heating up, an important new study, "The Bayh-Dole Act's Vital Importance to the U.S. Life-Sciences Innovation …
Dangers Lie in U.S. Government’s Conflicted Actions Toward Qualcomm, Huawei
5G, or 5th generation wireless communication, has reached the point of determining which core technologies will be used. Suddenly, decisions about which companies will be picked are …
Happy Birthday, Senator Birch Bayh
Hopefully, you've been fortunate enough—at least once in your life—to work for someone you really admired. That happened to me as a Senate Judiciary Committee …
Fine Tuning the Trump Administration’s ROI Initiative
The Trump Administration's Return on Investment (ROI) Initiative, which is geared toward increasing the American taxpayer's benefits from federally-supported R&D, is potentially a big step forward. …
Nokia Inks Patent Licensing Agreement With OPPO, A Rising Star in China’s Smartphone Industry
Nokia Corporation announced it entered into a patent licensing agreement with Chinese mobile consumer electronics firm OPPO. Although terms of the deal weren’t disclosed by Nokia, …
Enabling Technologies and the Underinvestment Problem
Certain innovations—known as enabling technologies—provide the foundation for progress across a range of industries. Enabling technologies include mobile wireless, the laser, CT scanners, the microprocessor, …
Want a greater ROI for taxpayers? Restore the patent system, protect Bayh-Dole and cut the red tape strangling federal labs
Three events boosted our economic turnaround in the 1980's: the passage of Bayh-Dole, which injected the incentives of patent ownership into the federal R&D system; the …
